Diabetes PHD (Personal Health Decisions) is a powerful new risk assessment tool. It can be used to explore the effects of a wide variety of health care interventions, including losing weight, stopping smoking, and taking certain medications.

What does Diabetes PHD do?

Ready? Click here to get your Diabetes PHD.

In order to provide the most accurate health information to you, Diabetes PHD will ask you to create a personal health record.  You will be asked to enter as much information as you can about your health history:  height, weight, cholesterol levels, blood pressure readings, last dilated eye exam, current medications, A1c number, etc. (Click here for a list of medical information you'll be asked for in order to use Diabetes PHD).

In a short time, Diabetes PHD will determine a personalized Results Overview for you, showing your current risk for diabetes, heart attack, stroke, kidney failure, as well as foot and eye complications. By changing certain variables in your profile, like stopping smoking, losing weight, taking ACE inhibitors, getting a regular foot exam etc., you will be able to see how making these changes would affect your future health. 

How does Diabetes PHD work?

Diabetes PHD is powered by Archimedes, a revolutionary health modeling program that brings together a vast range of clinical research data to make highly accurate predictions about health risk. Archimedes creates a “virtual reality” in which all the important objects and events in the real world match objects and events in the model’s world.  When a simulation model is run, the objects interact and events occur as they would in the real world. The software underpinning Diabetes PHD was developed by Kaiser Permanente with support from a grant to the American Diabetes Association from Bristol-Myers Squibb Co.

Ready?

Get your Diabetes PHD.

This tool was developed through the American Diabetes Association's Doing Better initiative, which is supported by an unrestricted educational grant from AstraZeneca LP, LifeScan, Inc., Novo Nordisk, Inc., and sanofi-aventis.